IP Library › Assignment 032175/0225
Patent Assignment
Reel/Frame 032175/0225

Change of Name

Recorded: 2014-02-07 Pages: 7
Assignor
ABBOTT BIOTHERAPEUTICS CORP.
Executed: 2012-11-26
Assignee
ABBVIE BIOTHERAPEUTICS INC.
1500 SEAPORT BLVD, REDWOOD CITY, CALIFORNIA, 94063
Covered Property (1)
Therapeutic Use of Anti-CS1 Antibodies
Patent: 9,175,081 →
Application: 13/894,857 →
Publication: US 2014/0065063
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 7, 2014
From: WILLIAMS, MARNA; TSO, J. YUN; LANDOLFI, NICHOLAS F.
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 032174/0919 →
Assignment of Assignor's Interest Feb 7, 2014
From: PDL BIOPHARMA, INC.
To: FACET BIOTECH CORPORATION
Reel/Frame 032175/0044 →
Assignment of Assignor's Interest Feb 7, 2014
From: LIU, GAO
To: PDL BIOPHARMA
Reel/Frame 032175/0099 →
Assignment of Assignor's Interest Feb 7, 2014
From: PDL BIOPHARMA, INC.
To: FACET BIOTECH CORPORATION
Reel/Frame 032175/0160 →
Change of Name Feb 7, 2014
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 032188/0810 →
Change of Name Feb 7, 2014
From: FACET BIOTECH CORPORATION
To: ABBOTT BIOTHERAPEUTICS CORP.
Reel/Frame 032188/0869 →